Stockscreener 앱 받기
4.00
1.23%
-0.05
시장 영업 전:
4.05
0.05
+1.25%
전일 마감가:
$4.05
열려 있는:
$4
하루 거래량:
404.56K
Relative Volume:
0.64
시가총액:
$275.39M
수익:
$113.02M
순이익/손실:
$-75.07M
주가수익비율:
-3.8362
EPS:
-1.0427
순현금흐름:
$-47.88M
1주 성능:
-3.85%
1개월 성능:
-6.87%
6개월 성능:
+42.35%
1년 성능:
+43.88%
1일 변동 폭
$3.93
$4.10
1주일 범위
$3.83
$4.24
52주 변동 폭
$2.08
$4.58
Orasure Technologies Inc Stock (OSUR) Company Profile
명칭
Orasure Technologies Inc
전화
(503) 641-6115
주소
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
4.00 | 272.64M | 113.02M | -75.07M | -47.88M | -1.0427 |
ISRG
Intuitive Surgical Inc
|
393.38 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.63 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
73.63 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
220.05 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
33.81 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-03 | 재개 | Evercore ISI | In-line |
| 2021-09-22 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | 개시 | Evercore ISI | Outperform |
| 2020-08-10 | 개시 | Citigroup | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
| 2020-08-07 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | 개시 | Lake Street | Buy |
| 2020-04-21 | 재개 | Stephens | Equal-Weight |
| 2018-10-23 | 재개 | Raymond James | Mkt Perform |
| 2018-07-16 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2017-02-09 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | 재확인 | Mizuho | Buy |
| 2015-05-07 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | 재확인 | Mizuho | Buy |
| 2014-06-12 | 재확인 | Canaccord Genuity | Buy |
| 2014-06-11 | 재확인 | Mizuho | Buy |
| 2012-12-21 | 개시 | Mizuho | Buy |
| 2012-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | 개시 | JMP Securities | Mkt Outperform |
모두보기
Orasure Technologies Inc 주식(OSUR)의 최신 뉴스
OraSure Technologies Inc (OSUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OraSure Technologies Inc (OSUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OSUR|OraSure Technologies Inc|Price:3.960|Chg%:-0.010 - TradingKey
OraSure Technologies Inc (OSUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OraSure Technologies Inc (OSUR) Cash Flow - TradingKey
OraSure Technologies Inc (OSUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OraSure Technologies, Inc. Revenue Breakdown – LSX:881351 - TradingView
OraSure Technologies, Inc. Revenue Breakdown – TRADEGATE:EP3 - TradingView
3 Promising Penny Stocks With Market Caps Over $60M - simplywall.st
OraSure Technologies Inc (OSUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to revenue forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
OraSure to announce Q2 2026 financial results on August 5 - scanx.trade
OraSure Technologies, Inc. (OSUR) stock price, news, quote and history - Yahoo Finance Singapore
OraSure's Q2 results webcast is set for Aug. 5 after market close - Stock Titan
Bethlehem’s OraSure gets FDA emergency authorization for Ebola test - Lehigh Valley Business
OraSure wins FDA emergency nod for Ebola test (OSUR:NASDAQ) - Seeking Alpha
OraSure receives Emergency Use Authorization for second generation Ebola test - WFMZ.com
AT&T, Cal-Maine Foods, OraSure Technologies - TradingView
Why Has OraSure Technologies (NASDAQ:OSUR) Entered Nasdaq News? - Kalkine Media
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th - Sahm
OraSure (OSUR) Secures FDA Approval for Enhanced Ebola Rapid Tes - GuruFocus
OraSure Technologies Gets Emergency Use Authorization From FDA for New Ebola Test - marketscreener.com
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test - The Manila Times
Enterprise value to revenue forward of OraSure Technologies, Inc. – MUN:EP3 - TradingView
OraSure Technologies (OSUR) Dips Below $3.90 as Selling Pressure MountsThematic ETF Flow - dars.gov.et
OraSure Technologies (OSUR) Slides 6.8% as Shares Test Critical Support Near $3.76Single Stock ETF - dars.gov.et
OraSure Technologies (OSUR) Slides 6.8% as Key Support Level Comes into FocusAI Trade Signals - dars.gov.et
Bethlehem's OraSure puts another property up for sale - WFMZ.com
OraSure Technologies stock holds steady as diagnostics business targets growth - AD HOC NEWS
OraSure Technologies updates highlight diagnostics focus amid shifting health trends - ad-hoc-news.de
OSUR Q1 2026 Earnings: Significant Earnings Miss as Losses WidenSaaS Earnings Trends - DonanımHaber
OSUROrasure Technologies Inc Latest SEC Filings - Finviz
Form 4 OraSure Technologies Inc For: 30 June By Investing.com - Investing.com Nigeria
OraSure Technologies (OSUR) director takes 3,666-share stock grant in lieu of cash - Stock Titan
Enterprise value to EBIT forward of OraSure Technologies, Inc. – MUN:EP3 - TradingView
Price to earnings forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
Price to book forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
Price to book forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Price to sales forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
Price to sales forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Enterprise value to revenue forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Price to earnings forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Enterprise value to EBITDA forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
OraSure Technologies Q1 2026 Earnings: EPS Misses Estimates as Stock Declines Over 4.9%Quarterly Earnings - DonanımHaber
OraSure gets FDA nod for at-home STI urine collection kit - Investing.com Nigeria
3 Promising Penny Stocks With At Least $200M Market Cap - simplywall.st
OraSure Technologies Hits New 52-Week High of $4.36, Marking Significant Growth - MarketsMojo
OraSure Technologies Inc (OSUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OraSure Technologies Inc (OSUR) Institutional Confidence - TradingKey
OraSure Technologies Inc (OSUR) Valuation: PE, PB & Fair Value Analysis - TradingKey
OraSure Technologies Inc (OSUR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Orasure Technologies Inc (OSUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Orasure Technologies Inc 주식 (OSUR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Boyd Steven Kyle | Director |
May 14 '26 |
Buy |
2.99 |
25,000 |
74,750 |
113,462 |
| Boyd Steven Kyle | Director |
May 12 '26 |
Buy |
2.98 |
25,000 |
74,500 |
63,462 |
| McGrath Kenneth J | Chief Financial Officer |
Mar 20 '26 |
Buy |
2.93 |
32,300 |
94,600 |
589,562 |
| EGLINTON MANNER CARRIE | President & CEO |
Mar 20 '26 |
Buy |
2.93 |
32,300 |
94,597 |
2,190,874 |
| McGrath Kenneth J | Chief Financial Officer |
Mar 13 '26 |
Buy |
3.00 |
22,021 |
66,030 |
557,262 |
| EGLINTON MANNER CARRIE | President & CEO |
Mar 13 '26 |
Buy |
3.00 |
22,022 |
66,033 |
2,158,574 |
1.37%
0.55%
자본화:
|
볼륨(24시간):